期刊文献+

恶性胃间质瘤的诊断与外科治疗 被引量:4

The Diagnosis and Surgical Treatment of Malignant Gastric Stromal Tumors
下载PDF
导出
摘要 目的探讨恶性胃间质瘤的诊断及治疗方法。方法对48例经手术治疗的恶性胃间质瘤的临床资料进行回顾性分析。结果本组中临床症状表现为上腹不适或疼痛29例,上消化道出血18例,腹部包块5例。行胃楔形切除术17例,近端胃大部切除术19例,远端胃大部切除术12例。肿瘤平均直径为7.2cm,胃周淋巴结转移2例(4.2%)。免疫组化结果CD117阳性46例(95.8%),CD34阳性39例(81.3%)。术后复发5例,远处转移6例,5年生存率为61.8%。结论恶性胃间质瘤的诊断主要依靠术后切片及免疫组化,治疗以手术为主,术后复发及转移的发生率较高,其预后主要与肿瘤大小相关。 Objective To investigate the diagnosis and surgical treatment of malignant gastric stromal tumors.Methods The clinical data of 48 cases with malignant gastric stromal tumor were analyzed retrospectively.Results The main symptom was abdominal pain ( 60.4% ), GI bleeding ( 37.5% ) and mass( 10.4% ). Wedge resections were performed on 17 patients and partial gastrectomies on 31 patients. The median size of tumors is 7.2cm in diameter, 2 of 48( 4.2% ) had lymph node metastasis. 10 of 48 patients recurred or metastasized. 46 of 48 ( 95.8% ) were positive for CD117, 39 positive for CD34. The 5 year survival rate in this series was 61.8% .Conclusion The primarily treatment of malignant gastric stromal tumors is surgical. Recurrence and metastasis were usual. Tumor size was found to be important indicator of the prognosis.
出处 《肿瘤防治研究》 CAS CSCD 2004年第11期697-699,共3页 Cancer Research on Prevention and Treatment
关键词 胃间质瘤 诊断 外科治疗 Gastric stromal tumors Diagnosis Surgical treatment
  • 相关文献

参考文献8

  • 1Mazur MT, Clark HB. Gastric stromal tumors: reappraisal of histogenesis[J]. Am J Surg Pathol, 1983,7(6):507-519.
  • 2Duffaud F, Blay JY. Gastrointestinal stromal tumors: biology and treatment[J].Oncology, 2003,65(3):187-197.
  • 3Trupiano JK, Stewart RE, Misick C, et al. Gastric stromal tumors[J]. Am J Surg Path,2002,26(6):705-714.
  • 4Kim CJ, Day S, Yeh K. Gastrointestinal stromal tumors: analysis of clinical and pathologic factors[J].Am Surg,2001,67(2):135-138.
  • 5Wu PC, Langerman A, Ryan CW, et al. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era[J].Surg,2003,134(4):656-664.
  • 6Sung JK. Surgery and prognostic facters for gastric stromal tumor[J]. World J Surg,2001,25(3):290-295.
  • 7Demetri GD, Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors[J].N Engl J Med,2002,347(7):472-480.
  • 8DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival[J].Ann Surg,2000,231(1):51-58.

同被引文献35

  • 1廖世兵,秦叔逵,王琳,邵志坚.格列卫新辅助治疗胃肠间质瘤[J].临床肿瘤学杂志,2004,9(3):244-246. 被引量:10
  • 2魏少忠,陈继红.胃肠道间质瘤的诊治[J].肿瘤防治研究,2004,31(10):659-660. 被引量:16
  • 3雷冬英,卢辉山.胃肠道间质瘤的诊断和治疗[J].福建医科大学学报,2005,39(1):69-71. 被引量:2
  • 4邵雪阳,唐宏兵,葛志刚.离子色谱法测定血液透析浓缩液中K^+、Na^+、Ca^(2+)、Mg^(2+)[J].中国卫生检验杂志,2006,16(10):1205-1206. 被引量:4
  • 5Van Oosterom AT, Judson J, Verweij E, et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours:a phase I study[J]. The Lancet, 2001,358(27):1421-1423.
  • 6Mazur MT, Clark HB. Gatric stromal tumors: reappraisal of histogenesis[J]. Am J Surg Pathol, 1983,7(16) : 507-519.
  • 7Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhabitor STI571 in a patient with a matastatic gastrointestinal stromal tumor[J]. N Eng J Med, 2001,344(14): 1052-1056.
  • 8廖世兵 秦叔逵.胃肠间质瘤的研究和治疗进展[J].解放军医学杂志,2003,28(8):12-17.
  • 9Blanks CD, von Mehren M, Tuveson S, et al. Evaluation of the safety and efficacy of an oral molecularly-targeted therapy,STI571, in patient with unresectable or metastatic expressing c-kit(CD117)[J]. Proc Am Soc Clin Oncol, 2001,20(pt 1):1 a. abstracts1.
  • 10Demetri GD, von Mehren M, Blande CD, et al. efficacy and safety of imatinib mesylate mesylate in advanced gastrointestinal stromal tumors[J]. N Eng J Med, 2002,347(7): 472-480.

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部